A review on curcumin colon-targeted oral drug delivery systems for the treatment of inflammatory bowel disease
- PMID: 36757584
- DOI: 10.1007/s10787-023-01140-0
A review on curcumin colon-targeted oral drug delivery systems for the treatment of inflammatory bowel disease
Abstract
Synthetic drugs and monoclonal antibodies are the typical treatments to combat inflammatory bowel disease (IBD). However, side effects are present when these treatments are used, and their continued application could be restricted by the high relapse rate of the disease. One potential alternative to these treatments is the use of plant-derived products. The use curcumin is one such treatment option that has seen an increase in usage in treating IBD. Curcumin is derived from a rhizome of turmeric (Curcuma longa), and the results of studies on the use of curcumin to treat IBD are promising. These studies suggest that curcumin interacts with cellular targets such as NF-κB, JAKs/STATs, MAPKs, TNF-α, IL-6, PPAR, and TRPV1 and may reduce the progression of IBD. Potentially, curcumin can be used as a therapeutic agent for patients with IBD when it reduces the incidence of clinical relapse. This review discusses the strategies utilized in designing and developing an oral colonic delivery dosage form of curcumin.
Keywords: Colon delivery; Curcumin; Gastrointestinal tract; IBD; Microparticles; Nanoparticles.
© 2023. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Similar articles
-
Curcumin and Its Modified Formulations on Inflammatory Bowel Disease (IBD): The Story So Far and Future Outlook.Pharmaceutics. 2021 Apr 2;13(4):484. doi: 10.3390/pharmaceutics13040484. Pharmaceutics. 2021. PMID: 33918207 Free PMC article. Review.
-
Curcumin has bright prospects for the treatment of inflammatory bowel disease.Curr Pharm Des. 2009;15(18):2087-94. doi: 10.2174/138161209788489177. Curr Pharm Des. 2009. PMID: 19519446 Review.
-
Curcumin, an active component of turmeric in the prevention and treatment of ulcerative colitis: preclinical and clinical observations.Food Funct. 2012 Nov;3(11):1109-17. doi: 10.1039/c2fo30097d. Food Funct. 2012. PMID: 22833299 Review.
-
Curcumin suppresses p38 mitogen-activated protein kinase activation, reduces IL-1beta and matrix metalloproteinase-3 and enhances IL-10 in the mucosa of children and adults with inflammatory bowel disease.Br J Nutr. 2010 Mar;103(6):824-32. doi: 10.1017/S0007114509992510. Epub 2009 Nov 2. Br J Nutr. 2010. PMID: 19878610
-
Use of curcumin and its nanopreparations in the treatment of inflammatory bowel disease.World J Gastroenterol. 2024 Jan 21;30(3):280-282. doi: 10.3748/wjg.v30.i3.280. World J Gastroenterol. 2024. PMID: 38314128 Free PMC article.
Cited by
-
Transcriptomic Insights into the Molecular Mechanisms of Indole Analogues from the Periplaneta americana Extract and Their Therapeutic Effects on Ulcerative Colitis.Animals (Basel). 2024 Dec 30;15(1):63. doi: 10.3390/ani15010063. Animals (Basel). 2024. PMID: 39795006 Free PMC article.
-
Curcumin@Fe/Tannic Acid Complex Nanoparticles for Inflammatory Bowel Disease Treatment.ACS Omega. 2024 Mar 14;9(12):14316-14322. doi: 10.1021/acsomega.3c10214. eCollection 2024 Mar 26. ACS Omega. 2024. PMID: 38559927 Free PMC article.
-
Preparation and evaluation of lipid-based sustained release pellets of chlorpheniramine maleate by the wet extrusion-spheronization method.Bioimpacts. 2024 Jul 8;15:30098. doi: 10.34172/bi.30098. eCollection 2025. Bioimpacts. 2024. PMID: 40161931 Free PMC article.
-
Oral enzyme-responsive nanoprobes for targeted theranostics of inflammatory bowel disease.J Nanobiotechnology. 2024 Aug 13;22(1):484. doi: 10.1186/s12951-024-02749-1. J Nanobiotechnology. 2024. PMID: 39138477 Free PMC article.
-
Protective effect of 5,4'-dihydroxy-6,8-dimethoxy7-O-rhamnosylflavone from Indigofera aspalathoides Vahl on lipopolysaccharide-induced intestinal injury in mice.Inflammopharmacology. 2024 Oct;32(5):3537-3551. doi: 10.1007/s10787-024-01530-y. Epub 2024 Aug 1. Inflammopharmacology. 2024. PMID: 39090500
References
-
- Agagunduz D, Sahin TO, Yilmaz B, Ekenci KD, Duyar Ozer S, Capasso R (2022) Cruciferous vegetables and their bioactive metabolites: from prevention to novel therapies of colorectal cancer. Evid Based Complement Alternat Med 2022:1534083. https://doi.org/10.1155/2022/1534083 - DOI - PubMed - PMC
-
- Ahir AA, Mali SS, Hajare AA, Bhagwat DA, Patrekar PV (2015) Pelletization technology: methods and applications-a review. Res J Pharm Technol 8(2):131 - DOI
-
- Alidadi M, Jamialahmadi T, Cicero AFG, Bianconi V, Pirro M, Banach M et al (2020) The potential role of plant-derived natural products in improving arterial stiffness: a review of dietary intervention studies. Trends Food Sci Technol 99:426–440. https://doi.org/10.1016/j.tifs.2020.03.026 - DOI